Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 2521 AL 2535

A Method for Electrical Stimulus Artifact Removal Exploiting Neural Refractoriness: Validation by Contrasting Cathodic and Anodic Stimulation

Nakhmani A, Block J, Awad M, Olson J, Smith R, Bentley JN, Holland M, Brinkerhoff SA, Gonzalez C, Moffitt M, Walker H.

bioRxiv [Preprint]. 2024 Oct 7:2024.10.06.616879. doi: 10.1101/2024.10.06.616879.

A pilot dose-finding study of Terazosin in humans

Schultz JL, Gander PE, Workman CD, Ponto LL, Cross S, Nance CS, Groth CL, Taylor EB, Ernst SE, Xu J, Uc EY, Magnotta VA, Welsh MJ, Narayanan NS.

medRxiv [Preprint]. 2024 May 22:2024.05.22.24307622. doi: 10.1101/2024.05.22.24307622.

Single-cell atlas of transcriptomic vulnerability across multiple neurodegenerative and neuropsychiatric diseases

Lee D, Koutrouli M, Masse NY, Hoffman GE, Kinrot S, Wang X, N M P, Pjanic M, Clarence T, Tsetsos F, Mathur D, Burstein D, Therrien K, Hong A, Casey C, Shao Z, Alvia M, Argyriou S, Fortes JM, Katsel P, Auluck PK, Barnes LL, Marenco S, Bennett DA; PsychAD Consortium; Jensen LJ, Girdhar K, Voloudakis G, Haroutunian V, Bendl J, Fullard JF, Roussos P.

medRxiv [Preprint]. 2024 Nov 4:2024.10.31.24316513. doi: 10.1101/2024.10.31.24316513.

African ancestry neurodegeneration risk variant disrupts an intronic branchpoint in GBA1

Jerez PÁ, Wild Crea PA, Ramos DM, Gustavsson EK, Radefeldt M, Makarious MB, Ojo OO, Billingsley KJ, Malik L, Daida K, Bromberek S, Hu C, Schneider Z, Surapaneni AL, Stadler J, Rizig M, Morris HR, Pantazis CB, Leonard HL, Screven L, Qi YA, Nalls MA, Bandres-Ciga S, Hardy J, Houlden H, Eng C, Burchard EG, Kachuri L; Global Parkinson’s Genetics Program (GP2); Singleton AB, Fischer S, Bauer P, Reed X, Ryten M, Beetz C, Ward M, Okubadejo NU, Blauwendraat C.

medRxiv [Preprint]. 2024 Feb 24:2024.02.20.24302827. doi: 10.1101/2024.02.20.24302827.

Aging hastens locomotor decline in PINK1 knockout rats in association with decreased nigral, but not striatal, dopamine and tyrosine hydroxylase expression

Soto I, McManus R, Navarrete-Barahona W, Kasanga EA, Doshier K, Nejtek VA, Salvatore MF.

bioRxiv [Preprint]. 2024 Feb 4:2024.02.01.578317. doi: 10.1101/2024.02.01.578317.

C/EBPβ: A transcription factor associated with the irreversible progression of Alzheimer's disease

Yao Q, Long C, Yi P, Zhang G, Wan W, Rao X, Ying J, Liang W, Hua F.

CNS Neurosci Ther. 2024 Apr;30(4):e14721. doi: 10.1111/cns.14721.

Continuous Subcutaneous Foslevodopa-Foscarbidopa in Parkinson's Disease: A Mini-Review of Current Scope and Future Outlook

Aubignat M, Tir M.

Mov Disord Clin Pract. 2024 Oct;11(10):1188-1194. doi: 10.1002/mdc3.14161. Epub 2024 Jul 11.

Large-fiber neuropathy in Parkinson's disease: a narrative review

Kwon EH, Steininger J, Scherbaum R, Gold R, Pitarokoili K, Tönges L.

Neurol Res Pract. 2024 Oct 28;6(1):51. doi: 10.1186/s42466-024-00354-z.

The role of voltage-gated calcium channels in the pathogenesis of Parkinson's disease

Sandoval A, Duran P, Corzo-López A, Fernández-Gallardo M, Muñoz-Herrera D, Leyva-Leyva M, González-Ramírez R, Felix R.

Int J Neurosci. 2024 May;134(5):452-461. doi: 10.1080/00207454.2022.2115905. Epub 2022 Nov 7.

Traditional Medicine Classification Based on the Nature and Location of Disease in Parkinson's Disease: A Clustering Study Using Pattern Identification Disassemble Presented in Clinical Studies

Jun P, Zhao H, Jung IC, Jang E, Kwon O, Jang JH.

J Integr Complement Med. 2024 Feb;30(2):99-106. doi: 10.1089/jicm.2023.0026. Epub 2023 Oct 11.

The VEGFs/VEGFRs system in Alzheimer's and Parkinson's diseases: Pathophysiological roles and therapeutic implications

Ceci C, Lacal PM, Barbaccia ML, Mercuri NB, Graziani G, Ledonne A.

Pharmacol Res. 2024 Mar;201:107101. doi: 10.1016/j.phrs.2024.107101. Epub 2024 Feb 7.

Sleep disorders cause Parkinson's disease or the reverse is true: Good GABA good night

Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Elewa YHA, Al-Farga A, Aqlan F, Zahran MH, Batiha GE.

CNS Neurosci Ther. 2024 Mar;30(3):e14521. doi: 10.1111/cns.14521.

Limonin (LM) and its derivatives: Unveiling the neuroprotective and anti-inflammatory potential of LM and V-A-4 in the management of Alzheimer's disease and Parkinson's disease

Panda SP, Kesharwani A, Singh M, Kumar S, Mayank, Mallick SP, Guru A.

Fitoterapia. 2024 Oct;178:106173. doi: 10.1016/j.fitote.2024.106173. Epub 2024 Aug 6.

Parkinson's disease models and death signaling: what do we know until now?

Pedrão LFAT, Medeiros POS, Leandro EC, Falquetto B.

Front Neuroanat. 2024 Oct 29;18:1419108. doi: 10.3389/fnana.2024.1419108. eCollection 2024.

Parkinsonian Syndrome Diagnosed via Novel Alpha-Synuclein Skin Biopsy in a Patient Presenting With Catatonic Symptoms

Biaggi N, Torres A, Verzura ML, Cruz J, Suarez R.

Cureus. 2024 Nov 11;16(11):e73441. doi: 10.7759/cureus.73441. eCollection 2024 Nov.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias